• Go to navigation
  • Go to content
Crestor

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca

Main navigation

  • Home
  • About CRESTOR®
  • About cardiovascular disease
  • Indication and efficacy
  • Prescribing information
  • Mechanism of action
  • Safety & side effects
  • Key CRESTOR® studies
  • Contact us

Welcome to CRESTOR.info

  • CRESTOR®
    (Rosuvastatin calcium)
    a comprehensive statin

    Reducing LDL, raising HDL, significant effects
    on atherosclerosis and beyond.
    For licensed indications and lipid effects see product information.

    For healthcare professionals only...

  • Prescription information

    Primary hypercholesterolaemia or mixed dyslipidaemia as an adjunct to diet…

    See full prescribing information

    Mechanism of action

    CRESTOR® is a statin: a competitive inhibitor of HMG-CoA reductase…

    Find out about the mechanism of action...

    Indication & Efficacy

    CRESTOR® beneficially modifies lipid parameters & is generally well tolerated.

    See changes to the full lipid profile...

  • CRESTOR® clinical studies

    • CRESTOR® clinical studies

      CRESTOR® clinical studies

      >65,000 subjects enrolled in GALAXY Programme to understand lipids and beyond…

      • Logo of Galaxy programme: studies of Crestor efficacy

        The GALAXY hypothesis proposes a link between lipids, atherosclerosis & outcomes.
        GALAXY Studies

        Logo for the Meteor study of rosuvastatin efficacy
        Changes in carotid intima media thickness demonstrated using B-mode ultrasound. METEOR

        Rosuvastatin is indicated for the treatment of dyslipidaemia. ONLY in some countries, it is also licensed to prevent the progression of atherosclerosis and/or the prevention of CV events.
        Please refer to your local prescribing information for details.

Page tools

  • Print
  • Bookmark this page

Header functions

    • AstraZeneca websites
    • Contact us

Crestor.info

  • About CRESTOR®

  • About Cardiovascular disease

  • Prescribing information

  • Mechanism of action

  • Safety & side effects

  • Key CRESTOR® studies

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010
  • Last updated: 09/03/2010

    • Legal notice
    • Privacy policy
    • Compliance information
    • ©2009 AstraZeneca 2010